Gilbert A. Fuller’s Form 4 filings reveal a consistent pattern of equity compensation and periodic liquidation, with no open-market purchases recorded across his 104 transactions. His activity spans just two tickers—USNA (USANA Health Sciences) and SNFCA (Security National Financial)—and the overall bias is decidedly toward selling: total open-market sales reached $299,988.68, while buy value stood at zero. The bulk of his acquired value, $1,062,739.83, came from grants (code A), option exercises (code M), and other non-purchase events, underscoring that his holdings are built through compensation rather than discretionary investment.
The most recent trades, all from 2026, show a clear selling cadence. On May 22, 2026, Fuller sold $19,728.69 worth of USNA stock, following a $17,986 sale on March 20, 2026, and a $22,704.25 sale on November 3, 2025. These USNA dispositions were paired with option exercises (coded M) in April and July 2026 at zero reported value, suggesting he was converting vested awards into cash. In SNFCA, the activity is more mechanical: quarterly grants (code A) and option exercises (code M) are immediately offset by shares surrendered to the issuer (code D) to cover tax liabilities, as seen on July 1, 2026, when a $5,254.48 award and exercise were matched by a $6,030.64 disposition.
The lone notable open-market sale in SNFCA occurred on April 7, 2026, when Fuller sold $94,500 worth of shares—by far the largest single transaction in the recent window. That sale, combined with the steady USNA liquidations, points to a deliberate reduction of his equity stake in both companies over the past year. There is no evidence of accumulation through purchases; every buy-side entry is tied to compensation mechanics, while every discretionary move has been a sale. The data suggests Fuller is monetizing his vested positions rather than adding to them, a trend that has accelerated in the first half of 2026.
AI-assisted summary